First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers
Clinical trial NCT06128382 · COMPLETED
Trial details
- NCT number
- NCT06128382
- Sponsor
- Osivax
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-08
- Primary completion
- 2024-07-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.